These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33978317)

  • 1. Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa Biofilms.
    Thorn CR; Carvalho-Wodarz CS; Horstmann JC; Lehr CM; Prestidge CA; Thomas N
    Small; 2021 Jun; 17(24):e2100531. PubMed ID: 33978317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Crystal Nanoparticles Enhance Tobramycin Efficacy in a Murine Model of
    Thorn CR; Wignall A; Kopecki Z; Kral A; Prestidge CA; Thomas N
    ACS Infect Dis; 2022 Apr; 8(4):841-854. PubMed ID: 35255215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid crystal nanoparticle platform for increased efficacy of cationic antimicrobials against biofilm infections.
    Thorn CR; Kopecki Z; Wignall A; Kral A; Prestidge CA; Thomas N
    Nanomedicine; 2022 Jun; 42():102536. PubMed ID: 35202839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
    Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.
    Rojo-Molinero E; Macià MD; Rubio R; Moyà B; Cabot G; López-Causapé C; Pérez JL; Cantón R; Oliver A
    Antimicrob Agents Chemother; 2016 May; 60(5):2912-22. PubMed ID: 26926631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Liquid Crystal Nanoparticles for Targeted Delivery of PslG: A Biofilm Dispersing Enzyme.
    Thorn CR; Raju D; Lacdao I; Gilbert S; Sivarajah P; Howell PL; Prestidge CA; Thomas N
    ACS Infect Dis; 2021 Aug; 7(8):2102-2115. PubMed ID: 33908759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
    J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin-coated pH-responsive dimeric prodrug-based nano-assemblies with high biofilm eradication capacity.
    Li X; Li W; Li K; Chen X; Wang C; Qiao M; Hong W
    Biomater Sci; 2023 Jan; 11(3):1031-1041. PubMed ID: 36545821
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms.
    Du J; Bandara HM; Du P; Huang H; Hoang K; Nguyen D; Mogarala SV; Smyth HD
    Mol Pharm; 2015 May; 12(5):1544-53. PubMed ID: 25793309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
    Murphy RA; Coates M; Thrane S; Sabnis A; Harrison J; Schelenz S; Edwards AM; Vorup-Jensen T; Davies JC
    Microbiol Spectr; 2022 Aug; 10(4):e0081322. PubMed ID: 35727066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
    Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
    Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
    Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M
    J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
    Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
    J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
    PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 18. Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections.
    Ho DK; Murgia X; De Rossi C; Christmann R; Hüfner de Mello Martins AG; Koch M; Andreas A; Herrmann J; Müller R; Empting M; Hartmann RW; Desmaele D; Loretz B; Couvreur P; Lehr CM
    Angew Chem Int Ed Engl; 2020 Jun; 59(26):10292-10296. PubMed ID: 32243047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
    Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD
    Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin.
    Halwani M; Blomme S; Suntres ZE; Alipour M; Azghani AO; Kumar A; Omri A
    Int J Pharm; 2008 Jun; 358(1-2):278-84. PubMed ID: 18448284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.